Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update

Lung cancer (LC) is the leading cause of cancer-related deaths, responsible for approximately 18.4% of all cancer mortalities in both sexes combined. The use of systemic therapeutics remains one of the primary treatments for LC. However, the therapeutic efficacy of these agents is limited due to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulbaqi, Ibrahim M., Assi, Reem Abou, Yaghmur, Anan, Darwis, Yusrida, Mohtar, Noratiqah, Parumasivam, Thaigarajan, Saqallah, Fadi G., Wahab, Habibah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400724/
https://www.ncbi.nlm.nih.gov/pubmed/34451824
http://dx.doi.org/10.3390/ph14080725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400724/
https://www.ncbi.nlm.nih.gov/pubmed/34451824
http://dx.doi.org/10.3390/ph14080725

Ejemplares similares